AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹3,484 Cr | ₹3,169 Cr | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr |
What is the latest Profit After Tax of AUROBINDO PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹3,484 Cr |
| Mar2025 | ₹3,169 Cr |
| Mar2024 | ₹1,928 Cr |
| Mar2023 | ₹2,647 Cr |
| Mar2022 | ₹5,334 Cr |
How is Profit After Tax of AUROBINDO PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,484 Cr | 9.93 | |
| Mar2025 | ₹3,169 Cr | 64.40 | |
| Mar2024 | ₹1,928 Cr | -27.18 | |
| Mar2023 | ₹2,647 Cr | -50.37 | |
| Mar2022 | ₹5,334 Cr | - | |
Compare Profit After Tax of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹99,831.9 Cr | 3.6% | 7.4% | 53.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.6% |
7.4% |
53.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses